PREMIUM
News

Endometriosis treatment now PBS-listed

Visanne will drop down from $800 a year to $380 a year or $90 for concession card holders.

Those living with endometriosis will have access to more affordable treatment with the drug dienogest now listed under the Pharmaceutical Benefits Scheme.

Hold tight - we’re checking permissions before loading more content